Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Novo Nordisk A/S (NVO) vs SoundHound AI Inc (SOUN) Price & Performance

Novo Nordisk A/STrade
SoundHound AI IncTrade

Price performance (Past 24H)

Key statistics

Novo Nordisk A/S vs SoundHound AI Inc — how do they compare? Novo Nordisk A/S trades at $49.32 (market cap $220.53B), while SoundHound AI Inc trades at $6.55 (market cap $2.75B). The key difference: Novo Nordisk A/S is far larger — about 80.2× SoundHound AI Inc's market cap, and Novo Nordisk A/S pays a 3.63% dividend while SoundHound AI Inc pays none. Which is the better fit depends on your goals.

NVOSOUN
Market Cap
$220.53B$2.75B
Sector
HealthTechnology
52-Week High
$71.70$21.40
52-Week Low
$35.29$5.90
Enterprise Value
$239.49B$2.54B
Dividend Yield
3.63%

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Novo Nordisk A/S

With almost 50% market share by volume of the global insulin market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments, and oral antidiabetic agents. Novo also has a biopharmaceutical segment (constituting roughly 15% of revenue) that specializes in protein therapies for hemophilia and other disorders.

Read more on NVO

About SoundHound AI Inc

SoundHound AI, Inc. is a leading innovator in voice artificial intelligence, specializing in conversational intelligence technology. The company develops a platform that allows businesses to add custom voice assistants and natural language processing capabilities to their products and services, ranging from in-car systems and smart speakers to mobile apps and IoT devices. SoundHound's core technology, including its proprietary speech recognition and natural language understanding models, aims to enable fast, accurate, and deeply integrated voice AI experiences across various industries.

Read more on SOUN